Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
3.110
+0.810 (35.22%)
Oct 3, 2025, 3:35 PM EDT

Nuo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
149662463014
Upgrade
Market Cap Growth
348.78%169.36%-61.19%2071893.52%-99.98%378.33%
Upgrade
Enterprise Value
149652460014
Upgrade
Last Close Price
3.111.400.551.500.000.45
Upgrade
PE Ratio
-----1.77
Upgrade
PS Ratio
76.3548.0139.99558.56--
Upgrade
PB Ratio
-180.59127.5923.4228.610.00-27.04
Upgrade
P/TBV Ratio
-127.5923.4228.610.00-
Upgrade
EV/Sales Ratio
76.2547.6439.48536.08--
Upgrade
Debt / Equity Ratio
-0.160.320.250.15--
Upgrade
Asset Turnover
1.400.890.250.05--
Upgrade
Inventory Turnover
2.441.680.56---
Upgrade
Quick Ratio
0.640.921.753.572.100.24
Upgrade
Current Ratio
0.851.462.324.392.180.24
Upgrade
Return on Equity (ROE)
--299.28%-196.34%-212.57%-62.68%-
Upgrade
Return on Assets (ROA)
-117.08%-100.16%-80.41%-91.97%-6.96%-107.90%
Upgrade
Return on Capital (ROIC)
-3267.86%-155.74%-103.64%-125.05%-39.17%-
Upgrade
Earnings Yield
-1.66%-3.55%-13.03%-5.06%-2996.37%-0.67%
Upgrade
FCF Yield
-0.74%-3.64%-13.05%-6.01%-3964.14%-0.40%
Upgrade
Buyback Yield / Dilution
-7.39%-7.95%-5.19%-32.03%-10.93%-15.13%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.